30 (88.2%) patients underwent unilateral surgery for breast cancer; the others 4 (15.8%) had bilateral surgery for cancer or BRCA1/2 mutation, for a total of 38 breasts. This evidence concerns the gene BRCA1 and breast carcinoma.